Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Haemonetics Corp (HAE)

Haemonetics Corp (HAE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,552,652
  • Shares Outstanding, K 46,471
  • Annual Sales, $ 1,361 M
  • Annual Income, $ 167,680 K
  • EBIT $ 285 M
  • EBITDA $ 415 M
  • 60-Month Beta 0.28
  • Price/Sales 1.85
  • Price/Cash Flow 7.50
  • Price/Book 2.76

Options Overview Details

View History
  • Implied Volatility 51.28% (-0.45%)
  • Historical Volatility 25.98%
  • IV Percentile 74%
  • IV Rank 57.12%
  • IV High 72.27% on 10/21/25
  • IV Low 23.32% on 03/17/26
  • Expected Move (DTE 17) 0.94 (1.66%)
  • Put/Call Vol Ratio 0.07
  • Today's Volume 60
  • Volume Avg (30-Day) 27
  • Put/Call OI Ratio 0.39
  • Today's Open Interest 1,870
  • Open Int (30-Day) 4,213
  • Expected Range 55.43 to 57.30

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $1.28
  • Number of Estimates 6
  • High Estimate $1.31
  • Low Estimate $1.26
  • Prior Year $1.24
  • Growth Rate Est. (year over year) +3.23%

Price Performance

See More
Period Period Low Period High Performance
1-Month
53.88 +4.60%
on 03/27/26
66.09 -14.72%
on 03/04/26
-6.96 (-10.99%)
since 02/27/26
3-Month
53.88 +4.60%
on 03/27/26
86.11 -34.55%
on 01/08/26
-23.92 (-29.80%)
since 12/26/25
52-Week
47.31 +19.12%
on 09/26/25
87.32 -35.46%
on 12/10/25
-6.83 (-10.81%)
since 03/28/25

Most Recent Stories

More News
Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System

VASCADE MVP XL now approved for larger sheaths used in market-leading PFA and LAAC technologies

HAE : 56.36 (+2.60%)
3 Small-Cap Stocks That Fall Short

3 Small-Cap Stocks That Fall Short

WERN : 29.41 (+2.69%)
HHH : 63.26 (+1.38%)
HAE : 56.36 (+2.60%)
2 Healthcare Stocks with Solid Fundamentals and 1 Facing Challenges

2 Healthcare Stocks with Solid Fundamentals and 1 Facing Challenges

ZTS : 118.21 (+1.62%)
HAE : 56.36 (+2.60%)
ELV : 292.75 (+2.80%)
A Look Back at Medical Devices & Supplies - Specialty Stocks’ Q4 Earnings: Haemonetics (NYSE:HAE) Vs The Rest Of The Pack

A Look Back at Medical Devices & Supplies - Specialty Stocks’ Q4 Earnings: Haemonetics (NYSE:HAE) Vs The Rest Of The Pack

HAE : 56.36 (+2.60%)
3 Reasons HAE is Risky and 1 Stock to Buy Instead

3 Reasons HAE is Risky and 1 Stock to Buy Instead

HAE : 56.36 (+2.60%)
3 Profitable Stocks with Open Questions

3 Profitable Stocks with Open Questions

ASGN : 38.71 (+1.23%)
GPC : 105.75 (+1.34%)
HAE : 56.36 (+2.60%)
Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology

BOSTON , Feb. 23, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today...

HAE : 56.36 (+2.60%)
Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference

BOSTON , Feb. 20, 2026 /PRNewswire/ --  Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Raymond James...

HAE : 56.36 (+2.60%)
5 Revealing Analyst Questions From Haemonetics’s Q4 Earnings Call

5 Revealing Analyst Questions From Haemonetics’s Q4 Earnings Call

HAE : 56.36 (+2.60%)
HAE Q4 Deep Dive: Plasma Momentum and Hospital Weakness Shape Mixed Results

HAE Q4 Deep Dive: Plasma Momentum and Hospital Weakness Shape Mixed Results

HAE : 56.36 (+2.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Relative Strength just crossed above 30%. The market has bounced from oversold territory. Beware of a potential mean reversion.

See More Share

Business Summary

Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood...

See More

Key Turning Points

3rd Resistance Point 59.64
2nd Resistance Point 58.37
1st Resistance Point 57.37
Last Price 56.36
1st Support Level 55.10
2nd Support Level 53.83
3rd Support Level 52.83

See More

52-Week High 87.32
Fibonacci 61.8% 72.04
Fibonacci 50% 67.32
Fibonacci 38.2% 62.60
Last Price 56.36
52-Week Low 47.31

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.